AKI-2

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAKI-2

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionAdenosine kinase inhibitors

TargetsAdenosine kinase

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSICOR Spa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSICOR Spa

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A

Related LinksN/A